Trial Details
TERMINATEDBasic Information
| Clinical ID | c1433 |
|---|---|
| Identifier | NCT05049525 |
| Trial Title | Evaluation of the Response of Itraconazole and Terbinafine Therapy in Subjects With Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease|Inflammatory Bowel Diseases |
| Interventions | DRUG: Itraconazole 400 mg/day and terbinafine 500 mg/day administered orally.|DRUG: Itraconazole's matching placebo 400 mg/day and terbinafine's matching placebo 500 mg/day administered orally. |
Participant Information
| Sponsor | Montreal Heart Institute |
|---|---|
| City | Quebec |
| Country/Region | Canada |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2022-02-22 |
|---|---|
| Primary Completion Date | 2024-02-28 |
| Completion Date | 2024-02-28 |